Naiyer A. Rizvi, MD

Naiyer A. Rizvi, MD

Episodes

Specialty:

All

Year:

All

EP. 1: Role of Immunotherapy in Oncology

December 22nd 2015

EP. 2: Measuring Immunotherapy Responses, Managing Toxicities in Lung Cancer

December 22nd 2015

EP. 3: Checkpoint Inhibition in NSCLC

December 22nd 2015

EP. 4: PD-L1 Testing and Patient Selection

December 22nd 2015

EP. 5: Combination Strategies in Lung Cancer

December 22nd 2015

EP. 6: Important Research Questions in Lung Cancer

December 22nd 2015

Trending on OncLive

Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma

ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC

Mo-Rez Advances Into Combination Studies Following Robust Responses in Gynecologic Cancers

mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC

FDA Grants Fast Track Designation to PLN-101095 Plus Pembrolizumab in Solid Tumors